Haizheng pharmaceutical: "acarbose tablet" new 100mg specification application approved
Haizheng pharmaceutical announced that the company has received the notice of approval of supplementary drug application for Acarbose Tablets approved and issued by the State Food and drug administration. This product is based on the company's approved Acarbose Tablets (specification: 50mg) and applies for a new specification of 100mg.
This text is a result of machine translation.
Related companies：
Briefing Oct 20, 2023 06:03 PM
· Technology
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
In-depth
Healthcare
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Briefing Sep 18, 2023 07:40 PM
· Technology
4Paradigm Initiates IPO Today and Targets HKSE on September 28
Briefing Feb 23, 2023 10:59 AM
· Technology
Power Device Company Maplesemi Completes Series A+ Financing Round
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
May 11, 2023 05:07 PM
Jan 05, 2023 07:33 PM
Briefing Feb 23, 2023 10:53 AM
· Technology
Acoustic Technology Company Audfly Completes Series B Financing Round
Briefing Feb 23, 2023 10:45 AM
· Technology
Wicue Raised CNY 200 Mn in Series C+ Financing Round
Briefing Feb 23, 2023 10:36 AM
· Technology
Intelligent Industrial Drone and UAV Systems Developer I-KINGTEC Closed A Series C+ Financing Round
Briefing Feb 23, 2023 10:34 AM
· Technology
Em-Data Technology Completed Strategic Financing Round
Briefing Sep 16, 2020 10:11 AM
· Consumer Staples
Guiding Price of Huazhu Group is HKD 297/Share
Briefing Sep 10, 2020 10:09 AM
· Consumer Staples
Huazhu Group Plans to IPO in Hong Kong
Briefing Jul 16, 2020 05:14 PM
· Consumer Staples
Huazhu Groups' Revenue to Fall by 32%~34% YoY
Briefing Jul 01, 2020 04:57 PM
· Consumer Staples
Huazhu Group Records a CNY 2.14 Billion Loss in 2020Q1
See more
Read next
Insight
In-depth
Insight
In-depth
Consumer Discretionary
Amazon Global Selling: A Decade of Growth in a Vast Market
Dec 17, 2024 05:43 PM
Insight
In-depth
Consumer Staples · Analysis
Din Tai Fung and the Globalization of Chinese Cuisine
Dec 03, 2024 08:26 PM
Insight
In-depth
Communication · Analysis
Podcast Marketing, A Useful Tool for Companies Going Overseas
Dec 02, 2024 02:15 PM